Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus

dc.contributor.authorYuksekkaya, Hasan A.
dc.contributor.authorArikan, Cigdem
dc.contributor.authorYazici, Ayse
dc.contributor.authorBaran, Masallah
dc.contributor.authorAydogdu, Sema
dc.contributor.authorKilic, Murat
dc.date.accessioned2019-10-27T20:52:19Z
dc.date.available2019-10-27T20:52:19Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.description.abstractSRL is a new and potent immunosuppressive agent that has been successfully introduced in organ transplantation. In contrast to other immunosuppressive agents, SRL has a potent antitumor activity both in vitro and in vivo. Herein, we report a child with Kaposi's sarcoma that was diagnosed 30 months after LDLT and treated successfully with only conversion to SRL monotherapy. KS regressed completely at the end of the first month and remained in remission during 28 months follow-up.en_US
dc.identifier.doi10.1111/j.1399-3046.2008.00944.xen_US
dc.identifier.endpage378en_US
dc.identifier.issn1397-3142
dc.identifier.issn1399-3046
dc.identifier.issue3en_US
dc.identifier.pmid18452496en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage375en_US
dc.identifier.urihttps://doi.org/10.1111/j.1399-3046.2008.00944.x
dc.identifier.urihttps://hdl.handle.net/11454/43218
dc.identifier.volume13en_US
dc.identifier.wosWOS:000264891700020en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectKaposi's sarcomaen_US
dc.subjectsirolimusen_US
dc.subjectimmunosuppressionen_US
dc.subjectpediatric liver transplantationen_US
dc.titleSuccessful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimusen_US
dc.typeArticleen_US

Dosyalar